electroCore, Inc. (ECOR) Discusses Neuromodulation Platform, Business Evolution, and Strategic Priorities Transcript
Source: SeekingAlpha
2025-12-26 00:36:11 ET
electroCore, Inc. (ECOR) Discusses Neuromodulation Platform, Business Evolution, and Strategic Priorities December 21, 2025 7:00 PM EST...
Read the full article on Seeking Alpha
For further details see:
electroCore, Inc. (ECOR) Discusses Neuromodulation Platform, Business Evolution, and Strategic Priorities Transcript
electroCore Inc.
NASDAQ: ECOR
ECOR Trading
2.04% G/L:
$7.49 Last:
15,396 Volume:
$7.50 Open:
ECOR Latest News
January 21, 2026 08:00:00 am
Acacia Clinics and Vagus Nerve Society Conduct Study Using electroCore's gammaCore Sapphire for Adjunctive Treatment of Symptoms Associated with Post-Traumatic Stress Disorder ("PTSD")
January 20, 2026 08:00:00 am
electroCore Provides Preliminary Full-Year 2025 Business Update; Expects ~26% Revenue Growth to ~$31.8-$32.0 Million
December 02, 2025 08:00:00 am
TAC-STIM Demonstrates Significant Performance Improvements in Active-Duty United States Air Force Airmen
November 10, 2025 04:05:00 pm
electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
ECOR Stock Data
$43,417,753
6,108,870
4.86%
16
N/A
Medical Equipment & Supplies
Healthcare
US
Rockaway
